FDA Inspection 1085143 — Kazi Hassan
The FDA completed an inspection of Kazi Hassan on March 19, 2019 in Saint Petersburg, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 19, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Saint Petersburg, FL (United States)
Additional Details
Clinical Investigator (CI)